{"id":391395,"date":"2020-12-02T03:35:34","date_gmt":"2020-12-02T08:35:34","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=391395"},"modified":"2020-12-02T03:35:34","modified_gmt":"2020-12-02T08:35:34","slug":"biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/","title":{"rendered":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>Mainz, Germany, December 02, 2020<\/strong><br \/>\n        <strong>(GLOBE NEWSWIRE)<\/strong> \u2013 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F5IjQ5p-se3Q6HOUs3UWVm-FLQjTRHAXZuFlcckm29pcj4OmJ9_3wCR-kdwihuu8h4cMqq8MRpfYTFMLlSYhxQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>BioNTech SE<\/u><\/a> (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Wednesday, December 2, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held in English:<\/p>\n<p>\n        <strong>International press conference at 12.30pm CET \/ 6.30am ET<\/strong><br \/>\n        <br \/>Please register <strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rlxcbwpnoE2s3-S-duutaqMJKnYUonQYziRRJybkHgB49uZiC5n5LtHl7nOcsiDp_Sf30LFVVXOSn31Yr_-8JTNAjoM9yJH7Caea702wm6Cqh-Hv6AbJidXm9_6Jyvwbb6hDe9Yn7Ufo6vjtvSOgHf-tbcaa3UbDU2h9Hq2TVMY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>here<\/u><\/a><\/strong>.<\/p>\n<p align=\"justify\">Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool. <\/p>\n<p align=\"justify\">Participants may also access the press conference, including the video webcast, on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NeG_ijgdhcfZg2CVr8JV48WjeADhYcYcqwYygjYRcixsQif4S8ctVivZsAuyhndflcvCTEqIf1F9IGYpXpSHlg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>https:\/\/biontech.de\/<\/u><\/a> under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media section of the website. A recording of the press conference will be available on the same day.\u00a0Additional media materials including images and videos can be accessed through the following link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c0OHbzF5cF5-JKjqA3VBmtM5iG7SRkeD-_H82FOo2hPYnRQEgWDmtZ11x8t4gyTUIJ53boQt2yCHJLCLJsuBKXePaLAM4LLXCt6tWqQ-veECazAjBqnczPS46PwDgT9o2s6kUkwLflSxYn2EsEu6rA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>press kit<\/u><\/a>.<\/p>\n<p>\u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <strong>About BioNTech<\/strong><br \/>\n        <\/strong><br \/>\n        <br \/>Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. <\/p>\n<p align=\"justify\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JcgUW-oi8R8ezZ6qr5XHzMoameSDCJ0rSmRxFqsb6_U512ljCiuBdKsvFBQ0RKFQu7yqygnpSc3bK88yb462ig==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.BioNTech.de<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>BioNTech Contacts<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>Jasmina Alatovic<br \/>Director External Communications<br \/>+49 (0)6131 9084 1513 or +49 (0)89 62 81 75 46<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CuLiL5lVKS9Y3d7ruF5Jy9u6pDYSLUZPxCcWpW7BhLi1o8jw5tVAnF1xh1VDBwZMwIg7ezRpjf946ctmNTeSPjlLHvTGm7sCR67wiXeAPY4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Media@biontech.de<\/u><\/a><\/p>\n<p align=\"justify\">\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Sylke Maas, Ph.D. <br \/>VP Investor Relations &amp; Business Strategy<br \/>+49 (0)6131 9084 1074<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zpOSX1jAIQv11I2y3k0NoaxERvn-DLSvttFr8Wzx3XgP5dYVvNafKOymspqHXbUz4xAl8eBcUBgybrunpyD9TJ3ib5ziGlEr2Guk-9q4vZI=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Investors@biontech.de<\/u><\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml-eu.globenewswire.com\/release\/track\/54b759c6-cb42-4538-b926-11dfe81fe859\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Mainz, Germany, December 02, 2020 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Wednesday, December 2, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held in English: International press conference at 12.30pm CET \/ 6.30am ET Please register here. Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool. Participants may also access the press conference, including the video webcast, on https:\/\/biontech.de\/ under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media section of the website. A recording of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-391395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Mainz, Germany, December 02, 2020 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Wednesday, December 2, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held in English: International press conference at 12.30pm CET \/ 6.30am ET Please register here. Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool. Participants may also access the press conference, including the video webcast, on https:\/\/biontech.de\/ under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media section of the website. A recording of the &hellip; Continue reading &quot;BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-02T08:35:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program\",\"datePublished\":\"2020-12-02T08:35:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/\"},\"wordCount\":325,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/\",\"name\":\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==\",\"datePublished\":\"2020-12-02T08:35:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/","og_locale":"en_US","og_type":"article","og_title":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk","og_description":"Mainz, Germany, December 02, 2020 (GLOBE NEWSWIRE) \u2013 BioNTech SE (Nasdaq: BNTX, \u201cBioNTech\u201d or \u201cthe Company\u201d) will hold a press conference including a video webcast on Wednesday, December 2, 2020, to provide an update on the status of the COVID-19 vaccine development program of its lead vaccine candidate BNT162b2. The event will be held in English: International press conference at 12.30pm CET \/ 6.30am ET Please register here. Interested journalists may dial in 10-15 minutes before the conference starts. They will be able to submit questions via an online tool. Participants may also access the press conference, including the video webcast, on https:\/\/biontech.de\/ under &#8220;Events &amp; Presentations&#8221; in the Investor &amp; Media section of the website. A recording of the &hellip; Continue reading \"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-02T08:35:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program","datePublished":"2020-12-02T08:35:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/"},"wordCount":325,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/","name":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==","datePublished":"2020-12-02T08:35:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDQ0MzUxNSM0MDA4MzE2MzQjMjAwMDk4NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biontech-to-hold-press-conference-to-provide-an-update-on-covid-19-vaccine-development-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=391395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=391395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=391395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=391395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}